Infinimmune Announces Partnership with Grid Therapeutics
19 Dec 2023 //
BUSINESSWIRE
Grid Therapeutics begins Phase II trial of NSCLC therapy
24 Feb 2023 //
CLINICAL TRIALS ARENA
Grid Initiates PII Investigator-Sponsored Trial of GT103 with Pembrolizumab
22 Feb 2023 //
BUSINESSWIRE
Grid Therapeutics Announces Presentation at the SITC 37th Annual Meeting
03 Nov 2022 //
BUSINESSWIRE
Grid Therapeutics Announces Enrollment of First Patient in Ph1 Study of GT103
24 Jun 2020 //
BUSINESSWIRE